Johannes Hulthe
Directeur/Bestuurslid bij GUARD THERAPEUTICS INTERNATIONAL AB
Oorsprong van het eerstegraads netwerk van Johannes Hulthe
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Pharmaceuticals: Major | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Johannes Hulthe via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ELECTROLUX AB | Electronics/Appliances | Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Investor Relations Contact | |
| COREM PROPERTY GROUP AB | Real Estate Development | Chairman Director/Board Member | |
| University of Adelaide | College/University | Investor Relations Contact | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Vitamex AB
 Vitamex AB Pharmaceuticals: MajorHealth Technology Vitamex AB develops and manufactures pharmaceutical products. It is licensed to produce VMS products, nutraceuticals, OTC products, and Rx pharmaceuticals. The company manufactures cosmetics, anti-oxidants, minerals, and vitamins. Its products include drugs for anxiety, pain, cold & flu, indigestion, weight management, cardiovascular diseases, and hair, skin as well as nails-related problems. Vitamex was founded in 1986 and is headquartered in Norrköping, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Masters Business Admin Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of Stockholm | College/University | Graduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| CAMURUS AB | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| Royal Institute of Technology | College/University | Undergraduate Degree Graduate Degree | |
| University of Lund | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Ernst & Young AB
 Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Ernst & Young AB provides tax advisory, auditing, and accounting services. It also offers support and advice on risk management, information technology security, and financial and business management. The company was founded in 1949 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree Graduate Degree | |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Gårdarike AB
 Gårdarike AB Real Estate DevelopmentFinance Gårdarike AB manages real estate properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
| Kabigen AB | Investor Relations Contact | ||
| CANTARGIA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member Founder | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Comptroller/Controller/Auditor | |
| INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director of Finance/CFO | |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| NOBINA AB (PUBL) | Other Transportation | Chairman Corporate Officer/Principal | |
| SCANDI STANDARD AB (PUBL) | Food: Meat/Fish/Dairy | Chairman Director/Board Member | |
Core Ventures LLC
 Core Ventures LLC Investment ManagersFinance Core Ventures LLC is an Independent Venture Capital firm founded in 2009. Core Ventures LLC is headquartered in Short Hills. | Investment Managers | Chief Investment Officer | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| NANEXA AB | Medical Specialties | Director/Board Member Chief Executive Officer | |
| DEVYSER DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
| Gårdarike Invest AB | Director/Board Member | ||
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
| M. Owens Management Consulting AB | Director/Board Member | ||
Lecra Group International AB
 Lecra Group International AB Investment Banks/BrokersFinance Lecra Group International AB provides securities management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
First Base AB
 First Base AB Data Processing ServicesTechnology Services First Base AB provides data processing and hosting services. The private company is based in Huddinge, Sweden. The CEO of the Swedish company is Michael Owens. | Data Processing Services | Chief Executive Officer | |
OT Lehmann Holding AB
 OT Lehmann Holding AB Investment Banks/BrokersFinance OT Lehmann Holding AB provides securities and property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Naventus Corporate Finance AB
 Naventus Corporate Finance AB Investment Banks/BrokersFinance Naventus Corporate Finance AB is an independent investment boutique and transaction manager headquartered in Stockholm, Sweden. The firm was founded by Lars Höckenström in 2017. Naventus Corporate Finance aims to, together with their clients, secure successful capital markets transactions and to achieve optimal results. They build a long-term strategy and strengthen value creation for clients. | Investment Banks/Brokers | Founder | |
| Synartro AB | Chairman | ||
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
| AB Consiliario | Director/Board Member | ||
| Gårdarike Fastigheter AB | Director/Board Member | ||
| OT Pharmaceuticals AB | Chief Executive Officer | ||
| Betulaceae Pharmaceuticals AB | Chairman Director/Board Member | ||
| Active Security Trading AB | Director/Board Member | ||
Active Biotech Research AB
 Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Actinova AB | Director/Board Member |
Statistieken
Internationaal
| Zweden | 46 |
| Verenigde Staten | 3 |
| Australië | 2 |
| Verenigd Koninkrijk | 2 |
| IJsland | 2 |
Sectoraal
| Health Technology | 17 |
| Finance | 11 |
| Consumer Services | 9 |
| Commercial Services | 3 |
| Consumer Durables | 2 |
Operationeel
| Director/Board Member | 99 |
| Corporate Officer/Principal | 34 |
| Director of Finance/CFO | 33 |
| Chairman | 29 |
| Independent Dir/Board Member | 23 |
Sterkste connecties
| Insiders | |
|---|---|
| Johan Bygge | 43 |
| Pia Magnhild Helena Gideon | 26 |
| Urban Paulsson | 25 |
| Michael Owens | 25 |
| Hugo Petit | 21 |
| Fredrik Lehmann | 17 |
| Lars Höckenström | 17 |
| Eva Pinotti Lindqvist | 10 |
| Göran Forsberg | 9 |
| Lars Ole Öhman | 9 |
| Eva Arlander | 8 |
| Jessica Martinsson | 7 |
| David Westberg | 7 |
| Klas Fredrik Tobias Werner | 6 |
| Karin Botha | 6 |
- Beurs
- Insiders
- Johannes Hulthe
- Bedrijfsconnecties